APA (7th ed.) Citation

Wen, X., Cai, L., Gao, A., Fu, A., Guo, D., & Zhu, M. (2025). Pharmacovigilance analysis of drug-induced hypofibrinogenemia using the FDA Adverse Event Reporting System. International Journal of Clinical Pharmacy, 47(3), 755-766. https://doi.org/10.1007/s11096-025-01867-6

Chicago Style (17th ed.) Citation

Wen, Xiao, Le Cai, Ao Gao, An Fu, Daihong Guo, and Man Zhu. "Pharmacovigilance Analysis of Drug-induced Hypofibrinogenemia Using the FDA Adverse Event Reporting System." International Journal of Clinical Pharmacy 47, no. 3 (2025): 755-766. https://doi.org/10.1007/s11096-025-01867-6.

MLA (9th ed.) Citation

Wen, Xiao, et al. "Pharmacovigilance Analysis of Drug-induced Hypofibrinogenemia Using the FDA Adverse Event Reporting System." International Journal of Clinical Pharmacy, vol. 47, no. 3, 2025, pp. 755-766, https://doi.org/10.1007/s11096-025-01867-6.